IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples